NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 211 filers reported holding NEVRO CORP in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,320,000 | +73.4% | 200,000 | +344.4% | 0.02% | +64.3% |
| Q2 2020 | $5,376,000 | -46.2% | 45,000 | -55.0% | 0.01% | -53.3% |
| Q1 2020 | $9,998,000 | -61.3% | 100,000 | -54.5% | 0.03% | -53.1% |
| Q4 2019 | $25,859,000 | +20.3% | 220,000 | -12.0% | 0.06% | +20.8% |
| Q3 2019 | $21,493,000 | -33.7% | 250,000 | -50.0% | 0.05% | -34.6% |
| Q2 2019 | $32,415,000 | -25.9% | 500,000 | -28.6% | 0.08% | -25.7% |
| Q1 2019 | $43,757,000 | +946.6% | 700,000 | +551.2% | 0.11% | +808.3% |
| Q4 2018 | $4,181,000 | -73.8% | 107,500 | -46.2% | 0.01% | -67.6% |
| Q2 2018 | $15,970,000 | +47.4% | 200,000 | +60.0% | 0.04% | +48.0% |
| Q1 2018 | $10,834,000 | -20.5% | 125,000 | -16.7% | 0.02% | -24.2% |
| Q3 2017 | $13,632,000 | +385.0% | 150,000 | +400.0% | 0.03% | +371.4% |
| Q1 2017 | $2,811,000 | -51.3% | 30,000 | -75.1% | 0.01% | -50.0% |
| Q1 2015 | $5,772,000 | -17.3% | 120,417 | -33.3% | 0.01% | -17.6% |
| Q4 2014 | $6,977,000 | – | 180,417 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |